Tableau de bordPortefeuillesListe de surveillanceCommunautéDécouvrirFiltre
NOT FOR DISTRIBUTION

Trupanion, Inc.

NasdaqGM:TRUP Rapport sur les actions

Capitalisation boursière : US$1.1b

  • Présentation de l'entreprise
  • Évaluation
  • Croissance future
  • Performances passées
  • Santé financière
  • Dividende
  • Gestion
  • Propriété
  • Autres informations
  • Communauté boursière

Trupanion Résultats passés

Passé contrôle des critères 5/6

Trupanion a connu une croissance annuelle moyenne de ses bénéfices de 45.7%, tandis que le secteur Insurance a vu ses bénéfices augmenter de en hausse à 14.7% par an. Les revenus ont augmenté de en hausse à un taux moyen de 17.1% par an. Le rendement des capitaux propres de Trupanion est 5.7% et ses marges nettes sont de 1.5%.

Informations clés

45.71%

Taux de croissance des bénéfices

45.99%

Taux de croissance du BPA

Insurance Croissance de l'industrie8.02%
Taux de croissance des recettes17.13%
Rendement des fonds propres5.67%
Marge nette1.53%
Dernière mise à jour des bénéfices30 Jun 2026

Mises à jour récentes des performances passées

Recent updates

User avatar
Mise à jour du récit • Sep 10

TRUP: Execution On Margin Discipline Will Drive Long Term Upside

The analyst price target for Trupanion has been revised lower by $3 to $34.25 as analysts factor in softer revenue growth, slightly thinner projected profit margins, and a reduced future P/E assumption, along with recent downgrades and cautious commentary on the company's operating backdrop. Analyst Commentary Recent research on Trupanion highlights a mixed but increasingly cautious tone, with valuation and execution closely tied to how the company handles a slower pet health demand backdrop and competitive pressure.
User avatar
Mise à jour du récit • Aug 26

TRUP: Lower Catastrophe Exposure Will Support Future Repricing As Demand Stabilizes

Analysts have trimmed Trupanion's fair value estimate from $45.00 to $42.00 as they factor in tougher pet insurance demand conditions, including weaker U.S. puppy vet visits and pressure on balancing premium growth with member retention and new-pet acquisition. Analyst Commentary Recent Street research on Trupanion highlights a mix of caution and optimism, with several firms refining their views as they reassess pet insurance demand, pricing power, and long term member growth.
Seeking Alpha • Aug 14

Trupanion: Profitable At Last, But Still Too Expensive To Buy (Upgrade)

Summary Trupanion’s estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025. Operating leverage and lower acquisition costs drove much of the improvement, while the H1 loss ratio also declined to 71.0% from 72.1%. Management’s 2026 guidance could imply $32–$40 million of net income, providing stronger evidence that scale is finally translating into profitability. Valuation remains demanding at more than 30x estimated 2026 earnings under my scenarios, limiting the attractiveness of the shares at current prices. I upgrade Trupanion from Sell to Hold as improving underwriting economics weaken the bearish case, although the valuation still prevents a Buy. Read the full article on Seeking Alpha
User avatar
Mise à jour du récit • Aug 08

TRUP: Capital Returns And Margin Focus Will Drive Long Term Upside

For Trupanion, the analyst price target has been trimmed to $37.25 from $39.75 as analysts factor in a slightly higher discount rate and more modest profit margins in their models, even as revenue growth assumptions and the implied future P/E move higher. Analyst Commentary Recent Street research on Trupanion shows a mix of optimism on execution and caution on risk, which helps explain the reset in price targets around the stock.
User avatar
Mise à jour du récit • Jul 15

TRUP: Lower Catastrophe Exposure Will Support Long-Term Repricing Potential

For Trupanion, the analyst price target in this narrative framework has shifted lower from $52.00 to $45.00. This reflects analyst adjustments to long term revenue growth, profit margin expectations, and the future P/E multiple following recent catastrophe related commentary.
User avatar
Mise à jour du récit • Jun 30

TRUP: Loyalty And Margin Execution Will Shape Prospective Earnings Upside

Trupanion's updated analyst price target has moved from $31.00 to $28.00 as analysts factor in slightly higher discount rates, a more moderate revenue growth outlook, and an adjusted future P/E assumption, while also reflecting recent Street target cuts. Analyst Commentary Recent Street commentary on Trupanion reflects a more cautious tone, with several bearish analysts trimming price targets and reassessing assumptions around growth, valuation, and execution risk.
User avatar
Mise à jour du récit • Jun 16

TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing

Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.
User avatar
Mise à jour du récit • Jun 01

TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside

Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.
User avatar
Mise à jour du récit • May 13

TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing

Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.
User avatar
Mise à jour du récit • Apr 22

TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns

Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.
User avatar
Mise à jour du récit • Apr 08

TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power

Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.
User avatar
Mise à jour du récit • Mar 25

TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential

Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.
User avatar
Mise à jour du récit • Mar 10

TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing

Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.
User avatar
Mise à jour du récit • Feb 24

TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential

Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.
User avatar
Mise à jour du récit • Feb 09

TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing

Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.
User avatar
Mise à jour du récit • Jan 25

TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power

Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.
User avatar
Mise à jour du récit • Jan 11

TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power

Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).
User avatar
Mise à jour du récit • Dec 27

TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power

Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).
User avatar
Mise à jour du récit • Dec 12

TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power

Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.
User avatar
Mise à jour du récit • Aug 10

Increasing Pet Ownership And Data Analytics Will Expand Market

The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.
User avatar
Nouveau récit • May 27

Global Expansion And Pricing Precision Will Shape Pet Markets

Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.
Article d’analyse • May 13

Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump

Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...
Article d’analyse • Feb 16

There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price

When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...
Seeking Alpha • Dec 13

Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer

Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking Alpha
Article d’analyse • Oct 25

Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%

Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...
Seeking Alpha • Sep 24

Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)

Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking Alpha
Article d’analyse • Aug 11

Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets

It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...
Article d’analyse • Jul 31

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...
Seeking Alpha • Jun 13

Trupanion: Growth First, Profitability Second

Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking Alpha
Article d’analyse • Feb 16

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...
Seeking Alpha • Feb 02

Trupanion: After All This Time, No Profits

Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking Alpha
Article d’analyse • Dec 18

A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb

Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...
Article d’analyse • Apr 18

What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash

The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...

Ventilation des recettes et des dépenses

Comment Trupanion gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NasdaqGM:TRUP Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 261,521231230
31 Mar 261,481261190
31 Dec 251,439191170
30 Sep 251,400151160
30 Jun 251,360111090
31 Mar 251,322-41030
31 Dec 241,286-10970
30 Sep 241,244-13950
30 Jun 241,203-19880
31 Mar 241,158-27830
31 Dec 231,109-45790
30 Sep 231,059-52810
30 Jun 231,007-61800
31 Mar 23956-61780
31 Dec 22905-45710
30 Sep 22854-42600
30 Jun 22801-36560
31 Mar 22750-32520
31 Dec 21699-36560
30 Sep 21647-32130
30 Jun 21596-28210
31 Mar 21545-17260
31 Dec 20502-6310
30 Sep 20465-2670
30 Jun 204342620
31 Mar 20408-2620
31 Dec 19384-2260
30 Sep 19361-3640
30 Jun 19340-2600
31 Mar 19321-1570
31 Dec 18304-1480
30 Sep 18288-1510
30 Jun 18273-2500
31 Mar 18259-2480
31 Dec 17244-2460
30 Sep 17228-2440
30 Jun 17214-4420
31 Mar 17200-6410
31 Dec 16188-7400
30 Sep 16177-8390
30 Jun 16167-11410
31 Mar 16156-15420
31 Dec 15147-17420
30 Sep 15139-18410

Des revenus de qualité: TRUP a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de TRUP sont plus élevées que l'année dernière TRUP. (1.5%) sont plus élevées que l'année dernière (0.8%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: TRUP est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 45.7% par an.

Accélération de la croissance: La croissance des bénéfices de TRUP au cours de l'année écoulée ( 110.8% ) dépasse sa moyenne sur 5 ans ( 45.7% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices TRUP au cours de l'année écoulée ( 110.8% ) a dépassé celle du secteur Insurance 27.4%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de TRUP ( 5.7% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/11 11:39
Cours de l'action en fin de journée2026/09/11 00:00
Les revenus2026/06/30
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
  • Formulaire 10-K de la SEC
  • Formulaire 10-Q de la SEC
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
  • Rapports de recherche des analystes
  • Blue Matrix
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
  • Données de marché ICE
  • Formulaire S-1 de la SEC
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
  • Formulaire 4 de la SEC
  • Formulaire 13D de la SEC
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
  • Formulaire 10-K de la SEC
  • Formulaire SEC DEF 14A
Principaux développements10 ans
  • Annonces de l'entreprise
  • Formulaire 8-K de la SEC

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Trupanion, Inc. est couverte par 16 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Christopher MerwinBarclays
Joshua ShankerBofA Global Research
Ryan TunisCantor Fitzgerald & Co.

Prenez de meilleures décisions d’investissement partout

Scannez pour télécharger
Ouvrir l’App StoreOuvrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Voir les sources de données
Marchés
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idées d'investissement
  • Sociétés sous-évaluées
  • Les géants du dividende
  • Achats d'initiés
  • Énergie nucléaire
  • Véhicules autonomes
  • Intelligence artificielle
  • Cryptomonnaie et blockchain
  • cybersécurité
  • Plus d'idées
Communautés boursières
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Outils et fonctionnalités
  • Suivi de portefeuille
  • Filtre et alertes sur les actions
  • Narratives et valeurs équitables
  • Calculateur de dividendes
Actualités et découvertes
  • Dernières actualités de stock
  • Aperçus du marché mondial
  • Le Foxhole
  • Idées d'investissement
  • Narratives de la communauté
  • Quoi de neuf
Simply Wall St
  • Plans et tarifs
  • Publicité
  • À propos de nous
  • Nous contacter
  • Carrières
  • Centre d'aide
  • Apprendre à investir en bourse
  • Programme d'affiliation
  • Affaires et entreprises
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Conditions générales d'utilisation
  • Politique de confidentialité
  • Conditions relatives à l'IA
  • Guide des services financiers